Gavi Announces New Partnerships To Accelerate Innovation and Expand Access to Immunisation

Gavi Announces New Partnerships To Accelerate Innovation and Expand Access to Immunisation

22 January, Davos – Gavi, the Vaccine Alliance today announced a series of new partnerships with leading global businesses, brands and philanthropic organisations aimed at accelerating innovation and expanding access to vaccines and primary health care for underserved communities.

“Gavi was created as a public–private partnership, and that model is more relevant than ever in today’s global health landscape,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “By combining innovation with strong new partnerships and the support of donors and governments, Gavi is helping countries move proven solutions beyond the pilot phase and into national systems at scale.”

The Gavi Innovation Scale-Up Facility (SUF): first announced at Gavi’s replenishment Summit in June 2025, the Scale-Up Facility is a unique mechanism designed to unlock private capital and scale-up proven innovations already in use across the immunisation value chain. It works by matching donors and investors with innovations that countries have successfully piloted and are looking to deploy more widely. Building on the anchor pledge of up to CAD 40 million made by Grand Challenges Canada (GCC) in June, this week Gavi announces that 500 Global intends to partner with Gavi and GCC to advance shared goals of sustainable scaling of innovations through the Scale-Up Facility. Together, Gavi, GCC and 500 Global aim to mobilise up to USD 300 million for the SUF to accelerate the scaling of high-impact innovations.

Gavi The Vaccine Alliance delivers largest shipment yet to DRC in support of international mpox response

“At the heart of this work is one mission: saving lives and turning innovations into lasting change. By partnering with Gavi, Grand Challenges Canada, and other collaborators, we can reach those who are most underserved, and by aligning partners to absorb different risks, we can deploy capital more efficiently and scale proven solutions in fragile and emerging settings. Strategic risk-taking can unlock transformative health outcomes, and we invite others to join this vital work,” Dr. Alaa Murabit, Managing Partner, Sustainable Growth, 500 Global

The Coca-Cola Foundation has also pledged support to Gavi’s Innovation Scale Up Facility (SUF) by providing countries and enterprises access to technical assistance to help scale SUF-supported innovations. This work will be conducted through TCCF-funded partnerships Project Last Mile and Next Mile Ventures.

Improving equitable access to primary healthcare and vaccine uptake: Though a new, multi-partner initiative, Netherlands-based chocolate manufacturer Tony’s Chocolonely, with its impact engine and sourcing platform Tony’s Open Chain, along UBS Optimus Foundation and Bayer Foundation have partnered with Gavi to reduce health costs, enhance overall access to primary healthcare and tackle low vaccination rates for families living in cocoa-farming communities across Ghana and Côte d’Ivoire. Implemented by Elucid in alignment with Ministries of Health, the initiative will enable the expansion of service delivey via mobile clinics, training for community health care workers, improvements to cold-chain infrastructure and support for national health insurance enrolment via digital technologies such as mobile money and health insurance applications. With initial support by the Gavi Dutch Matching Fund, 140,000 children are targeted in the first three years and more than 600,000 people are expected to benef across both countries.

Expanding drone delivery: Gavi’s long-standing partnership with Zipline, which facilitates the delivery of vaccines to remote communities via drones, has been expanded to Nigeria. The expansion, which will see drone deliveries used to reach zero-dose communities across Kaduna State has been enabled by additional support from the Elton John AIDS Foundation and with exceptional support by Sweden.

These partnerships underscore Gavi’s long-standing commitment to using innovation and public–private collaboration partnership model to ensure that more children, in more communities, can be reached with life-saving vaccines and essential health services.

About Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world’s deadliest diseases. The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Gates Foundation and other private sector partners. View the full list of donor governments and other leading organisations that fund Gavi’s work here.

Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs innovative finance and the latest technology – from drones to biometrics – to save lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency